European Commission homes in on dual pricing by pharma companies
This article was originally published in SRA
Executive Summary
In a move aimed at establishing how pharmaceutical companies are dealing with the question of parallel trade, the European Commission has asked a number of firms in Spain for information on how they price their products for sale to wholesalers1.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.